【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Cytoxan
04.1.2 Vidaza
04.1.3 Dacogen
04.1.4 Idamycin PFS
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Etiology and Risk Factors
07.3 Pathophysiology
07.4 Epidemiology
07.5 Classification
07.5.1 FAB Classification
07.5.2 WHO Classification
07.6 Diagnosis
07.6.1 Blood Samples
07.6.2 Bone Marrow Samples
07.6.3 Spinal Fluid
07.6.4 CBC and Peripheral Smear
07.6.5 Blood Chemistry and Coagulation Tests
07.6.6 Microscopic Exams
07.6.7 Cytochemistry
07.6.8 Flow Cytometry and Immunohistochemistry
07.6.9 Cytogenetics
07.6.10 FISH and PCR
07.6.11 X-Ray
07.6.12 CT Scan
07.6.13 Ultrasound
07.6.14 MRI Scan
07.7 Treatment and Management
07.7.1 Induction Therapy
07.7.2 Post Remission Therapy
07.8 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Class of Drugs
09.1 Alkylating Agent
09.2 Cytotoxic Antibiotic
09.3 Topoisomerase Inhibitor
09.4 Others
10.Geographical Segmentation
11.Buying Criteria
12.Market Growth Drivers
13.Drivers and their Impact
14.Market Challenges
15.Impact of Drivers and Challenges
16.Market Trends
17.Trends and their Impact
18.Pipeline Portfolio
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Celgene
19.2.2 Johnson & Johnson
19.2.3 Pfizer
19.2.4 Bristol Myers Squibb
19.3 Other and Future Prominent Vendors
20.Key Vendor Analysis
20.1 Bristol Myers Squibb
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Revenue by Business Segmentation
20.1.5 Revenue Comparison 2013 and 2014
20.1.6 Sales by Geography
20.1.7 Business Strategy
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Celgene
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Revenue by Business Segmentation
20.2.5 Revenue Comparison 2013 and 2014
20.2.6 Sales by Geography
20.2.7 Business Strategy
20.2.8 Key Developments
20.2.9 SWOT Analysis
20.3 Johnson and Johnson
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue by Business Segmentation
20.3.5 Revenue Comparison 2013 and 2014
20.3.6 Sales by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Pfizer
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Business Segmentation
20.4.4 Revenue by Business Segmentation
20.4.5 Revenue Comparison 2013 and 2014
20.4.6 Sales by Geography
20.4.7 Business Strategy
20.4.8 Key Developments
20.4.9 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of Acute Myeloid Leukemia
Exhibit 3: Percentage of Acute Myeloid Leukemia Cases in Comparison with Other Types of Leukemia in the US 2014
Exhibit 4: FAB Classification of Acute Myeloid Leukemia
Exhibit 5: FAB Classification of Acute Myeloid Leukemia and the Percentage of Patients in Each Class
Exhibit 6: Percentage Distribution of Acute Myeloid Leukemia Patients According to the FAB Classification
Exhibit 7: The WHO Classification of Acute Myeloid Leukemia
Exhibit 8: Treatment Options for Acute Myeloid Leukemia
Exhibit 9: Treatment Options for Relapsed Acute Myeloid Leukemia
Exhibit 10: Snapshot of the Economic Burden of Acute Myeloid Leukemia
Exhibit 11: Cost Per Patient in Different Treatment Cycles in the US (2012)
Exhibit 12: Cost Per Patient in Different Treatment Cycles in the UK (2012)
Exhibit 13: Snapshot of the Global Acute Myeloid Leukemia Therapeutics Market, 2014
Exhibit 14: Global Acute Myeloid Leukemia Therapeutics Market 2014-2019 (US$ million)
Exhibit 15: Global Acute Myeloid Leukemia Therapeutics Market Segmentation by Class of Drugs
Exhibit 16: Global Acute Myeloid Leukemia Therapeutics Market Segmentation by Class of Drugs 2014
Exhibit 17: Global Acute Myeloid Leukemia Therapeutics Market by Geographical Segmentation 2014
Exhibit 18: Buying Criteria of Global Acute Myeloid Leukemia Therapeutics Market
Exhibit 19: Phase III Pipeline Molecules for Acute Myeloid Leukemia
Exhibit 20: Global Acute Myeloid Leukemia Therapeutics Market Share Analysis 2014
Exhibit 21: Authorization Details of Vidaza
Exhibit 22: Regulatory History of Dacogen
Exhibit 23: Authorization Details of Dacogen
Exhibit 24: Bristol-Myers Squibb: Business Segmentation 2014
Exhibit 25: Bristol-Myers Squibb: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 26: Bristol-Myers Squibb: Sales by Geography (in US$ million)
Exhibit 27: Celgene: Business Segmentation by Revenue 2013 and 2014
Exhibit 28: Celgene: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 29: Celgene: Sales by Geography 2014 (Diagnostics Division)
Exhibit 30: Johnson & Johnson: Business Segmentation by Revenue 2014
Exhibit 31: Johnson & Johnson: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 32: Johnson & Johnson: Sales by Geography 2014
Exhibit 33: Pfizer: Business Segmentation
Exhibit 19: Pfizer: Revenue by Business Segmentation 2014
Exhibit 20: Pfizer: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 21: Pfizer: Revenue by Geographical Segmentation 2014
【レポート販売概要】
■ タイトル：急性骨髄性白血病（AML）治療薬の世界市場2015-2019■ 英文：Global Acute Myeloid Leukemia Therapeutics Market 2015-2019
■ 発行日：2014年12月24日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4899
■ 調査対象地域：グローバル
- ICT投資の優先順位：ユーティリティー産業部門 – 企業のICT投資計画Why was the report written? In order to provide deeper insights into utilities’ ICT investment priorities and strategic objectives. What is the current market landscape and what is changing? Kable’s survey reveals that utilities are spending on core technologies as well as advanced technologies such as cloud and mobility to remain competitive in the market. What are the key drivers behind recent m …
- Fluorosilicic Acidの世界市場Fluorosilicic Acid (CAS 16961-83-4) Market Research Report 2013 presents comprehensive data on fluorosilicic acid markets globally and regionally (Europe, Asia, North America etc.) The report includes fluorosilicic acid description, covers its application areas and related patterns. It overviews fluorosilicic acid market, names fluorosilicic acid producers and indicates its suppliers. Besides, the …
- Lyrica (Epilepsy)：市場予測と分析（～2022）Lyrica (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lyrica (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED ma …
- クラスター弾の世界市場2016-2020About Cluster Munitions A cluster munition is an air-dropped or ground-launched explosive weapon that ejects smaller submunitions. Cluster bombs release explosive projectiles, which are designed to destroy vehicles, disperse chemical or biological weapons, scatter landmines, and kill personnel. These cluster bombs release many small munitions over a wide area, posing risks to civilians both during …
- リグノセルロース・バイオ燃料分析Biofuels have emerged as a widely used renewable source of energy in the recent years. However, the rising demand for biofuels in developed as well as developing countries has put a lot of pressure on feedstocks such as corn, sorghum, and soy, which are food crops. To ease off this pressure on food crops, scientists around the world are working on methods to convert lignocelluloses from plant wast …
- 自動車用潤滑油の世界市場：エンジンオイル、トランスミッションフルード、ブレーキオイルThe global automotive lubricant market was valued at $4,403.0 million in 2014, and is expected to reach $6,839.9 million by 2019, growing at a CAGR of 9.2% from 2014 to 2019. Asia-Pacific is expected to hold a market share, in terms of volume, of 51% of the global automotive lubricant market by 2019, growing at a CAGR of 7.6% from 2014 to 2019. The automotive lubricant market is segregated into fo …
- スマート抗菌性コーティング及び表面の世界市場Smart antimicrobial coatings and surfaces represent an important element of the smart materials space. The market for smart antimicrobial coatings and surfaces is driven by the need to selectively combat new threats from bacteria, viruses and fungi. Also important to the future of smart antimicrobial coatings is the mandate to reduce hospital-acquired infections. But, the opportunity for antimicro …
- OTCブレース及びサポートの世界市場予測（～2024年）“The OTC braces and supports market is projected to grow at a CAGR of 5.1% during the forecast period” The OTC braces and supports market is projected to reach USD 1.5 billion by 2024 from USD 1.2 billion in 2019, at a CAGR of 5.1%. The growth in this market is majorly driven by the increasing prevalence of orthopedic diseases & disorders, rising number of sports and accident-related injuries, and …
- 世界のソフトウェア試験システムインテグレーター市場動向（2012-2016）TechNavio's analysts forecast the Global Software Testing System Integrator market to grow at a CAGR of 21.15 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased availability of testing applications. The Global Software Testing System Integrator market has also been witnessing the shift in focus toward cloud-based testing. However, the diff …
- グローバル・ビックデータサービス市場動向（2014-2018）About Big Data Services Big data services are a wide range of services required for processing and analyzing enterprise data, which is too large for traditional data processing tools. This data is generated from various sources such as mobile devices, digital repositories, and enterprise applications and ranges from terabytes (10^12 bytes) to petabytes (10^15 bytes) and even exabytes (10^18 bytes) …
- GaN（窒化ガリウム）パワーデバイスの世界市場予測（～2022）The global GaN power devices market is estimated to reach USD 2.60 Billion by 2022, at a CAGR of 24.5% from 2015 to 2022. One of the major driving factors for the GaN semiconductor devices market is the RF semiconductor devices industry. The parent, that is, RF electronics industry, has slightly different requirements with respect to characteristics of its electronic devices, components, and semic …
- 世界の人材管理市場動向（2012-2016）TechNavio's analysts forecast the Global Human Capital Management market to grow at a CAGR of 10.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the streamlining of human resource operations. The Global HCM market has also been witnessing the emergence of SaaS-based HCM solutions. However, the fragmentation of the market could pose a challenge to …
- 包装資材・容器の世界市場：紙・板紙、プラスチック、金属、ガラス、紙、フレキシブル箔About Containers and Packaging Containers and packaging products can be manufactured using a number of raw materials such as metal, plastic, paper, glass, and fiber. The Global Containers and Packaging market comprises of products manufactured for packaging purposes and are used by numerous end-users including the Food, Beverage, Healthcare, Toiletries, Personal Care sectors, and other industrial …
- 製薬業界における提携、ライセンシング、投資、M&A動向（2014年2月）Partnerships, Licensing, Investments and M&A Deals and Trends for February 2014 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2014 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report pro …
- 商用航空機ヘルスモニタリングシステム/統合機体ヘルスマネジメント（IVHM）技術の世界市場This report provides a market analysis of the aircraft health monitoring systems market, over the next six years. It contains an analysis of the drivers, challenges, and restraints that affect the industry, along with their impact from the short, medium, and long term perspectives landscapes. It also discusses the industry, market, and technology trends that currently, prevail in the market. The r …
